Multi-national clinical trial shows effectiveness of amantadine in treatment of traumatic brain injury

A multi-national study published today in the New England Journal of Medicine revealed a significant breakthrough in the treatment of patients in vegetative and minimally conscious states. The study showed that the drug amantadine hydrochloride accelerated the pace of functional recovery during active treatment in patients with post-traumatic disorders of consciousness.

The study, funded by a 5-year, $3 million grant from the National Institute on Disability and Rehabilitation Research, involved 184 patients at 11 clinical trial sites in three countries. JFK Johnson Rehabilitation Institute in Edison, NJ and MossRehab in Philadelphia served as the lead centers for the international study. The patients involved were receiving inpatient rehabilitation and were in a vegetative or minimally between four and 16 weeks after . During the four week treatment period, recovery was significantly faster among patients who were administered than those in the .

Study leader, Joseph T. Giacino, Ph.D, who now serves as Director of Rehabilitation Neuropsychology at Spaulding Rehabilitation Hospital said, "The results of this study provide convincing evidence that it is possible to increase the speed of recovery from severe traumatic brain injury when treatment is initiated within four months of onset. These findings engender optimism for a medical condition that is often viewed as untreatable."

The study results pave the way for additional studies of a drug whose therapeutic value was previously undetermined. "Now that we know that amantadine can accelerate neurologic recovery, we need to explore the dose and treatment schedule that provides the greatest and most durable treatment impact," said study co-leader, John Whyte, M.D., Ph.D, Director of Moss Rehabilitation Research Institute. "Importantly, this study adds to the growing evidence that patients with disorders of consciousness have rehabilitation potential that we are just beginning to tap."

Journal information: New England Journal of Medicine
Provided by Spaulding Rehabilitation Network
Citation: Multi-national clinical trial shows effectiveness of amantadine in treatment of traumatic brain injury (2012, March 12) retrieved 24 April 2024 from https://medicalxpress.com/news/2012-03-multi-national-clinical-trial-effectiveness-amantadine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study: Old flu drug speeds brain injury recovery

 shares

Feedback to editors